GRIFOLS traded at 17.99 this Friday July 1st, decreasing 0.05 or 0.25 percent since the previous trading session. Looking back, over the last four weeks, GRIFOLS lost 4.54 percent. Over the last 12 months, its price fell by 19.47 percent. Looking ahead, we forecast GRIFOLS to be priced at 17.91 by the end of this quarter and at 16.19 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
17.99
Daily Change
-0.25%
Yearly
-19.47%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Alcon AG 66.40 -0.28 -0.42% 2.15%
Almirall SA 10.62 0.04 0.38% -28.68%
Amarin 1.49 -0.33 -18.13% -66.59%
Amadeus IT 53.30 0.14 0.26% -10.96%
argenx SE 362.20 4.70 1.31% 43.11%
Artemis Alpha 293.00 -6.50 -2.17% -32.72%
AstraZeneca 10,722.00 -78.00 -0.72% 22.65%
Bayer 56.52 -0.20 -0.35% 9.81%
Cie Automotive 23.90 0.22 0.93% -7.15%
Essilor 144.55 1.65 1.15% -5.18%
Ence Energia y Celulosa SA 3.21 -0.05 -1.53% -7.70%
Ferrovial 24.14 -0.05 -0.21% -5.15%
Fresenius Medical Care 47.44 -0.19 -0.40% -31.29%
Fresenius 28.68 -0.22 -0.76% -35.74%
Genmab 2,312.00 15.00 0.65% -10.46%
Galapagos 53.00 -0.04 -0.08% -9.18%
GRIFOLS 17.99 -0.05 -0.25% -19.47%
GlaxoSmithKline 1,755.60 -10.00 -0.57% 22.09%
Hikma Pharmaceutical 1,600.50 -17.00 -1.05% -36.99%
Inditex 22.14 0.55 2.55% -25.55%
Merck 163.15 2.15 1.34% 0.22%
Novartis 79.19 -1.66 -2.05% -6.20%
Philips 20.38 -0.18 -0.85% -49.94%
Roche Holding 315.10 -3.45 -1.08% -10.01%
Sanofi 96.23 -0.11 -0.11% 9.48%
Smith & Nephew PLC 1,126.50 -21.00 -1.83% -29.22%
UCB 80.84 0.20 0.25% -9.76%
Viscofan 52.35 -0.15 -0.29% -10.89%
William Demant Holding 266.70 0.40 0.15% -25.57%

Indexes Price Day Year
ES35 8185 86.54 1.07% -8.11%

GRIFOLS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.